This profile has not been claimed and data may not be accurate.
Founder72
45th percentile
Investor16
50th percentile
YC S17Serial FounderAcquiredRaised $20M+Angel Investor
Founder Matrix
Credibility
this founder typical founder (50th pct)
Operator · 84th percentile
- Current founder and CEO of Women's Health Platform, a stealth women's health company.
- Y Combinator Summer 2017 alum via Modern Fertility.
- Past founder of Modern Fertility and Kera10 (now Virtue Labs).
- Modern Fertility was co-founded with Carly Leahy, confirming a co-founder relationship.
Founder score
- 97%Probability of being accurate (97%)Y Combinator Summer 2017 alum via Modern Fertility.
- 95%Probability of being accurate (95%)Modern Fertility raised $22M in total venture funding from investors including Union Square Ventures, Forerunner Ventures, First Round Capital, and Y Combinator.
- 95%Probability of being accurate (95%)Modern Fertility was acquired by Ro for approximately $225M in 2021.
- 95%Probability of being accurate (95%)Past founder of Modern Fertility and Kera10 (now Virtue Labs).
- 92%Probability of being accurate (92%)Modern Fertility was co-founded with Carly Leahy, confirming a co-founder relationship.
- 85%Probability of being accurate (85%)Current founder and CEO of Women's Health Platform, a stealth women's health company.
- 45%Probability of being accurate (45%)Modern Fertility was named the number one most innovative company in healthcare by Fast Company and achieved triple-digit annual growth, indicating strong commercial traction consistent with profitability.
Investor score
- 80%Probability of being accurate (80%)Publicly identified as an angel investor and advisor to healthcare companies through her role at 43G.
- 75%Probability of being accurate (75%)Has been investing and advising healthcare companies since at least January 2023, representing approximately two years of investing experience.
What you likely need
You're a proven founder with a high-profile exit and strong YC pedigree, now building a second company in stealth while actively investing in healthcare. Your next chapter is about establishing Women's Health Platform as a credible, fundable venture and leveraging your network and track record to accelerate it. Formalizing your investor identity alongside your founder role could unlock additional deal flow and co-investment opportunities.
Are these your current priorities?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- fundraisingLeverage your $225M exit and YC S17 track record to run a targeted seed raise for Women's Health Platform, prioritizing your existing backers (USV, Forerunner, First Round) who already know your execution style.
- positioningTime your public launch announcement for Women's Health Platform to coincide with a press moment (e.g., a funding close or product milestone) to maximize earned media given your existing Fortune 40 Under 40 and Fast Company profile.
- fundraisingFormalize your 43G investing activity into a named angel syndicate or micro-fund to attract LP capital and increase your deal flow in women's health and femtech.
- hiringRecruit a technical co-founder or CTO for Women's Health Platform early, given that Modern Fertility's success was partly driven by a strong co-founder dynamic with Carly Leahy.
- introsTap the YC alumni network for warm introductions to Series A investors who have backed women's health or digital health companies in recent batches.
- positioningContinue publishing research and op-eds on women's health (as you did at Modern Fertility) to build category authority for Women's Health Platform before the product launches.
- wellbeingSet a clear internal milestone for when Women's Health Platform exits stealth to avoid the psychological and operational drag of an indefinite stealth phase.